Thus, the electroporation of established colon tumors with a plasmid coding for CXCL9 together with IL-12 increases the CD8 T-cell recruitment and delays the tumor growth, either alone or in combination with an anti-PD-1 Ab [62]. Here, CXCL9 is linked to neoplasm.